The following definitions apply throughout this chapter:

1. (1) "COVID-19" means:

   1. (A) severe acute respiratory syndrome coronavirus 2 or a mutated form of severe acute respiratory syndrome coronavirus 2; or
   2. (B) the disease caused by severe acute respiratory syndrome coronavirus 2 or a mutated form of severe acute respiratory syndrome coronavirus 2.

2. (2) "COVID-19 protective product" means one (1) or more of the following:

   1. (A) Personal protective equipment.
   2. (B) Medical devices, equipment, and supplies used to treat COVID-19, including medical devices, equipment, or supplies that are used or modified for an unapproved use to treat COVID-19 or to prevent the spread of COVID-19.
   3. (C) Medical devices, equipment, and supplies used outside of their normal use to treat COVID-19 or to prevent the spread of COVID-19.
   4. (D) Medications used to treat COVID-19, including medications prescribed or dispensed for off label use to attempt to treat COVID-19.
   5. (E) Tests, as approved by the federal Food and Drug Administration, to diagnose or determine immunity or exposure to COVID-19.
   6. (F) A product designed to clean or disinfect to prevent the spread of COVID-19.
   7. (G) Any component of an item described in this subdivision.
3. (3) "Manufacturer or supplier" means a person who designs, manufactures, labels, sells, distributes, or donates a COVID-19 protective product.

As added by P.L.1-2021, SEC.8.